Guillermo Godinez

Guillermo Godinez is a scientific researcher with extensive experience in biotechnology and pharmacology. Currently working at Vividion Therapeutics, Inc. since April 2022, Guillermo previously held positions at Merck as a Scientist II, where notable contributions included establishing rodent models for age-related diseases and developing various analytical techniques. At Rigel Pharmaceuticals Inc., Guillermo served as a Senior Associate Scientist II, contributing to the development of clinical candidates and designing high-throughput muscle performance platforms. Earlier experience includes work at Cytokinetics, where Guillermo contributed to multiple clinical candidate developments and managed laboratory operations. Educational qualifications include a Bachelor of Science in Cell & Molecular Biology and Biochemistry from San Francisco State University, along with a Master of Fine Arts in Motion Pictures & Television from the Academy of Art University.